Bruce Hart
Consigliere Generale presso Zymeworks BC, Inc.
Provenienza dei contatti di primo grado di Bruce Hart
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.
27
| Subsidiary | Biotechnology | 27 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Bruce Hart tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Sales & Marketing | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| LIMINAL BIOSCIENCES INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| Aventis, Inc. | Corporate Officer/Principal | ||
| University of Pennsylvania | College/University | Doctorate Degree | |
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Missouri | College/University | Masters Business Admin | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal | |
| University of Alberta | College/University | Doctorate Degree | |
| University of British Columbia | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Medical Specialties | Corporate Officer/Principal | |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| Alberta Bar Association | Corporate Officer/Principal | ||
British Columbia Bar Association
 British Columbia Bar Association Miscellaneous Commercial ServicesCommercial Services British Columbia Bar Association Operates as a law firm association to provide legal services. The company is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member | |
| Dream Foundation | Director/Board Member | ||
| FOUNDATION MEDICINE INC | Medical/Nursing Services | Chief Executive Officer | |
| IMMUNEERING CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Biosplice Therapeutics, Inc.
 Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| SOPHIA GENETICS SA | Packaged Software | Chairman | |
| University of Glasgow School of Medicine | College/University | Doctorate Degree | |
UCB Biopharma SRL
 UCB Biopharma SRL Medical DistributorsDistribution Services Part of UCB SA, UCB Biopharma SRL is a Belgian pharmaceutical company founded in 2013. The company is based in Brussels, Belgium. UCB Biopharma specializes in the development of treatments for various medical conditions, including axial spondyloarthritis, psoriatic arthritis, and other health issues. The company also manages the UCB Community Health Fund and holds an annual shareholders meeting. | Medical Distributors | Corporate Officer/Principal | |
LetsGetChecked, Inc.
 LetsGetChecked, Inc. Medical SpecialtiesHealth Technology LetsGetChecked, Inc. operates online platform which connects customers and diagnostic laboratories. It offers its diagnostics services for general health, sexual health, cancer screening and fertility and hormone check. The company was founded by Peter Foley in 2014 and is headquartered in Dun Laoghaire, Ireland. | Medical Specialties | Director/Board Member | |
| ZENTALIS PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Lengo Therapeutics, Inc.
 Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lengo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Link Immunotherapeutics, Inc.
 Link Immunotherapeutics, Inc. Medical/Nursing ServicesHealth Services Link Immunotherapeutics, Inc. is a holding company, which engages in combination therapies. Its biotechnology is dual biscpecifics. The company was founded in 2019 and is headquartered in Seattle, WA. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| Think Forwards | Corporate Officer/Principal Chief Executive Officer | ||
| 23ANDME HOLDING CO. | Biotechnology | Corporate Officer/Principal | |
| ZYMEWORKS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer President Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Investor Relations Contact Chief Tech/Sci/R&D Officer General Counsel Director of Finance/CFO Chief Tech/Sci/R&D Officer Public Communications Contact | |
MRM Proteomics, Inc.
 MRM Proteomics, Inc. BiotechnologyHealth Technology MRM Proteomics, Inc. provides proteomics services. Its products include PeptiQuant, protein quant and quality control kits. The firm offers PeptiQuant protein quantitation, protein characterization and tissue imaging services. The company was founded in 2010 and is headquartered in Montreal, Canada. | Biotechnology | Director/Board Member | |
| STANDARD BIOTOOLS INC. | Miscellaneous Commercial Services | Chairman | |
ImStar Therapeutics, Inc.
 ImStar Therapeutics, Inc. BiotechnologyHealth Technology ImStar Therapeutics, Inc. develops therapies for ALS and neurodegenerative disease. The firm's lead drug candidate is IMS-088, a small-molecule compound currently in preclinical development. It is studying compounds directed at a proprietary new therapeutic target for ALS called TANA. The company was founded by Daniel J. Wattier and Jean-Pierre Julien in 2012 and is headquartered in Vancouver, Canada. | Biotechnology | Founder |
Statistiche
Distribuzione geografica
| Stati Uniti | 35 |
| Canada | 12 |
| Belgio | 3 |
| Svizzera | 3 |
| Regno Unito | 2 |
Settori
| Health Technology | 28 |
| Commercial Services | 7 |
| Consumer Services | 7 |
| Health Services | 4 |
| Finance | 3 |
Posizioni
| Director/Board Member | 93 |
| Corporate Officer/Principal | 50 |
| Independent Dir/Board Member | 30 |
| Chief Tech/Sci/R&D Officer | 19 |
| Undergraduate Degree | 17 |
Contatti più connessi
| Insiders | |
|---|---|
| Ken Galbraith | 30 |
| Susan Mahony | 21 |
| Troy Cox | 19 |
| Hollings Renton | 17 |
| Diana Hausman | 13 |
| Kelvin Neu | 13 |
| Ali Tehrani | 13 |
| Kenneth Hillan | 10 |
| Carlos Campoy | 10 |
| Christopher Astle | 10 |
| Neil Klompas | 9 |
| Jennifer Kaufman-Shaw | 8 |
| Nick Bedford | 8 |
| Paul Moore | 7 |
| Neil Josephson | 6 |
- Borsa valori
- Insiders
- Bruce Hart
- Connessioni Società